Zhou Q. CRISPR/Cas9 in Antibody Engineering: Advances in Cell Line Optimization and Therapeutic Applications. AJST [Internet]. 2025 Dec. 28 [cited 2026 Jul. 29];18(1):57-62. Available from: https://drpress.org/ojs/index.php/ajst/article/view/32214